OCM
VNRX icon

Ovata Capital Management’s VolitionRx Ltd VNRX Stock Holding History

Ovata Capital Management’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-124
Closed -$10K – 63
2020
Q4 		$10K Sell
124
-2,376
-95% -$164K ﹤0.01% 48
2020
Q3 		$161K Hold
2,500
– – 0.06% 54
2020
Q2 		$195K Buy
+2,500
New +$181K 0.06% 62

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ovata Capital Management's VNRX Position: Q1 2021 in Review

Ovata Capital Management sold out of VolitionRx Ltd (VNRX) in Q1 2021, closing a stake of 124 shares — an estimated $10K sold.

Ovata Capital Management first reported a position in VNRX in Q2 2020 and held it in 3 quarters. The position peaked at $195K in Q2 2020. 57 funds tracked by Wall St. Rank hold VNRX as of Q1 2021.

  • Ovata Capital Management reported no remaining VolitionRx Ltd position as of Q1 2021 after selling out during the quarter.
  • Ovata Capital Management sold 124 VolitionRx Ltd shares in Q1 2021, an estimated $10K.
  • Ovata Capital Management first reported a position in VolitionRx Ltd in Q2 2020 and held it in 3 quarters.
  • Ovata Capital Management's VolitionRx Ltd position peaked at $195K in Q2 2020.
  • 57 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2021.

Based on Ovata Capital Management's 13F filing for Q1 2021, filed 17 May 2021.